Table 1

Cycle threshold (Ct) values of the individual and pool samples for the validation and study groups

Pool sizePool sample Ct target EIndividual sample Ct target EPool sample Ct target N2Individual sample Ct target N2
Validation samples*
 529.527.733.430.6
 530.026.633.029.5
 529.726.332.527.6
 529.726.632.829.2
 5†14.613.317.515.7
 5†15.113.317.515.7
 5†15.413.317.915.7
 530.729.233.731.5
 532.829.836.333.2
 5†30.028.432.930.7
 5†30.328.433.330.7
 5†30.728.433.730.7
 532.829.336.132.3
Study samples with positive pool results
 436.034.739.137.4
 4042.340.238.5
 332.330.634.733.3
 5‡0038.70
 40038.539.2
 5040.940.338.8
 3‡0042.90
 5035.540.337.4
 50042.2+
 535.338.1+
 5‡0041.40
 50041.640.6
 536.7+37.2+
 5‡0043.40
 535.9+40.3+
 536.2+39.5+
 50043.7+
 4‡38039.90
 2‡0042.70
 5035.841.638.0
 538.035.339.436.5
 440.937.739.138.4
 40043.840.4
 525.923.828.125.8
 50041.238.0
 526.624.529.126.8
 5‡39.5038.00
 527.6+29.9+
 5‡0042.70
 5‡0043.10
 50040.438.7
 4‡0044.30
 542.541.100
 4‡43.7040.70
 528.126.230.428.9
  • *Only 9 of 15 positive validation samples with available Ct values were included in the table.

  • †Validation samples tested thrice to evaluate the reproducibility of the pooling method.

  • ‡Discordant study samples showing positive pool tests and negative individual tests. The negative results of all the individual samples were confirmed at an outside laboratory.

  • §Ct values are not generated for positive samples with ‘+’ sign.

  • E, envelope; N2, nucleic acid.